Pliant Therapeutics Inc (PLRX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $43.21M
Last updated: Nov 17, 2026 at 11:06 AM ET
Pliant Therapeutics Inc (PLRX) Earnings: Report Dates and Results
Pliant Therapeutics (PLRX) is expected to report earnings on Mar 9, 2027. In the quarter ended Sep 30, 2026, Pliant Therapeutics reported EPS of -$0.39, below the -$0.37 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
PLRX has an expected report date of Mar 9, 2027.
Earnings History
Of the 26 quarters below that had an estimate, PLRX beat 12, missed 13 and matched 1. The widest gap in the table came in the quarter ended Jun 30, 2020, when EPS landed 104.41% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.39 | -$0.37 | -$0.39 - -$0.36 | -5.41% | Miss | N/A | 3 | 0 up, 2 down | Nov 12, 2026 | N/A |
| Jun 30, 2026 | -$0.36 | -$0.33 | -$0.37 - -$0.32 | -9.09% | Miss | N/A | 4 | 3 up, 0 down | Aug 11, 2026 | N/A |
| Mar 31, 2026 | -$0.32 | -$0.36 | -$0.38 - -$0.33 | +11.11% | Beat | N/A | 5 | 1 up, 0 down | May 11, 2026 | N/A |
| Dec 31, 2025 | -$0.35 | -$0.42 | -$0.42 - -$0.34 | +14.97% | Beat | N/A | 5 | 1 up, 0 down | Mar 11, 2026 | N/A |
| Sep 30, 2025 | -$0.43 | -$0.52 | -$0.66 - -$0.41 | +17.31% | Beat | N/A | 8 | 0 up, 1 down | Nov 6, 2025 | N/A |
| Jun 30, 2025 | -$0.71 | -$0.62 | -$1.09 - -$0.48 | -14.52% | Miss | N/A | 8 | 3 up, 5 down | Aug 7, 2025 | N/A |
| Mar 31, 2025 | -$0.92 | -$0.75 | -$0.87 - -$0.38 | -22.67% | Miss | N/A | 9 | 5 up, 0 down | May 8, 2025 | N/A |
| Dec 31, 2024 | -$0.82 | -$0.96 | -$1.05 - -$0.92 | +14.15% | Beat | N/A | 10 | 0 up, 0 down | Mar 3, 2025 | $2.27M |
| Sep 30, 2024 | -$0.95 | -$0.98 | -$1.15 - -$0.87 | +3.06% | Beat | N/A | 12 | 1 up, 0 down | Nov 7, 2024 | N/A |
| Jun 30, 2024 | -$0.92 | -$0.85 | -$0.93 - -$0.80 | -8.24% | Miss | N/A | 12 | 0 up, 0 down | Aug 7, 2024 | N/A |
| Mar 31, 2024 | -$0.78 | -$0.77 | -$0.83 - -$0.66 | -1.30% | Miss | N/A | 13 | 0 up, 0 down | May 6, 2024 | N/A |
| Dec 31, 2023 | -$0.69 | -$0.81 | -$1.15 - -$0.71 | +14.81% | Beat | N/A | 13 | 0 up, 0 down | Feb 27, 2024 | $4.84M |
| Sep 30, 2023 | -$0.70 | -$0.77 | -$0.88 - -$0.68 | +9.09% | Beat | N/A | 13 | 0 up, 0 down | Nov 9, 2023 | N/A |
| Jun 30, 2023 | -$0.70 | -$0.69 | -$0.85 - -$0.51 | -1.45% | Miss | N/A | 12 | 0 up, 0 down | Aug 9, 2023 | $248000 |
| Mar 31, 2023 | -$0.67 | -$0.67 | -$0.78 - -$0.59 | 0.00% | In line | N/A | 12 | 0 up, 0 down | May 9, 2023 | $1.33M |
| Dec 31, 2022 | -$0.72 | -$0.70 | -$0.75 - -$0.62 | -2.86% | Miss | N/A | 12 | 0 up, 0 down | Mar 9, 2023 | $1.97M |
| Sep 30, 2022 | -$0.65 | -$0.74 | -$0.83 - -$0.67 | +12.16% | Beat | N/A | 10 | 0 up, 0 down | Nov 8, 2022 | $1.48M |
| Jun 30, 2022 | -$0.82 | -$0.81 | -$0.86 - -$0.77 | -1.23% | Miss | N/A | 9 | 0 up, 0 down | Aug 8, 2022 | $4.99M |
| Mar 31, 2022 | -$0.78 | -$0.74 | -$0.79 - -$0.70 | -5.41% | Miss | N/A | 7 | 0 up, 0 down | May 9, 2022 | $1.25M |
| Dec 31, 2021 | -$0.68 | -$0.76 | -$0.89 - -$0.64 | +10.53% | Beat | N/A | 7 | N/A | Feb 28, 2022 | $2.00M |
| Sep 30, 2021 | -$0.75 | -$0.69 | -$0.77 - -$0.63 | -8.70% | Miss | N/A | 5 | N/A | Nov 9, 2021 | $1.61M |
| Jun 30, 2021 | -$0.64 | -$0.67 | -$0.71 - -$0.60 | +4.48% | Beat | N/A | 5 | N/A | Aug 9, 2021 | $1.79M |
| Mar 31, 2021 | -$0.64 | -$0.60 | -$0.66 - -$0.56 | -6.67% | Miss | N/A | 5 | N/A | May 10, 2021 | $2.17M |
| Dec 31, 2020 | -$0.54 | -$0.71 | -$1.05 - -$0.55 | +23.94% | Beat | N/A | 4 | N/A | Mar 16, 2021 | $4.46M |
| Sep 30, 2020 | -$0.47 | -$0.60 | -$1.49 - -$0.55 | +21.67% | Beat | N/A | 4 | N/A | Nov 10, 2020 | $4.81M |
| Jun 30, 2020 | -$1.39 | -$0.68 | -$1.05 - -$0.50 | -104.41% | Miss | N/A | 4 | N/A | Aug 11, 2020 | $3.60M |
| Mar 31, 2020 | -$0.20 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 3, 2020 | $28.94M |
| Jun 30, 2019 | -$0.21 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 17, 2019 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$2.41, after -$3.47 the year before. It was -$2.81 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$2.41 | N/A |
| Dec 31, 2024 | -$3.47 | N/A |
| Dec 31, 2023 | -$2.76 | N/A |
| Dec 31, 2022 | -$2.97 | N/A |
| Dec 31, 2021 | -$2.71 | N/A |
| Dec 31, 2020 | -$2.81 | N/A |
Frequently Asked Questions About PLRX
When is Pliant Therapeutics's next earnings date?
Pliant Therapeutics's next earnings report is expected for Mar 9, 2027.
Did PLRX beat earnings estimates last quarter?
No. Pliant Therapeutics reported EPS of -$0.39 for the quarter ended Sep 30, 2026, below the -$0.37 estimate by 5.41%.
What EPS do analysts expect from PLRX next quarter?
The consensus EPS estimate for Pliant Therapeutics for the quarter ending Dec 31, 2026 is -$0.38 from 6 analysts, with estimates from -$0.38 to -$0.38.
How often does PLRX beat earnings estimates?
Pliant Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +0.73%.
PLRX pages: Overview, Earnings, Forecast, Financials, Competitors